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Effect of ethacrynic acid on the thick ascending limb
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Effect of ethacrynic acid on the thick ascending limb of Henle's
loop. Cortical thick ascending limbs of Henle's loop were dis-
sected from rabbit kidneys and perfused in vitro. The diuretic
ethacrynic acid (10—i M) in the tubule lumen caused a reversible
decrease in the electrical PD. Ethacrynic-cysteine complex, a
major urinary excretion product of ethacrynic acid, also caused
a reversible decrease in the PD as well as in net chloride trans-
port, but at a much lower concentration (3 x lO M) in the
lumen. Ethacrynic-cysteine in the bath (1O M) had no effect
on the PD. Ethacrynic-cysteine had little effect on Na and Cl
conductances, measured electrically. On the basis of these results
we suggest that the ethacrynic-cysteine complex is the major
active form of the drug in vivo and that it acts in the lumen of
the thick ascending limb of Henle's loop to inhibit active Cl
transport and thereby diminish NaC1 reabsorption.
Effet de l'acide éthacrynique sur Ia partie large de Ia branche
ascendante de l'anse de Henle. Des branches ascendantes larges
corticales d'anses de Henle ont été disséquées a partis de veins
de lapins et perfusées in vitro, L'acide éthacrynique (lOs M)
dans Ia lumière tubulaire determine une inhibition reversible de
Ia difference de potentiel electrique. Le complexe ethacrynique-
cystCine, un produit d'excrCtion urinaire majeur de l'acide
éthacrynique, determine aussi une diminution reversible de la
difference de potentiel et du transport net de chlore, mais a une
concentration luminale moindre (3 x lO M). Le complexe
éthacrynique-cysteine dans Ic bain n'a pas d'effet sur Ia diffé-
rence de potential. Le complexe a peu d'effets sur les conduc-
tances Na et Cl mesurées electriquement. Sur Ia base de ces
résultats, nous suggerons que Ic complexe ethacrynique-cysteine
est le forme active majeure de Ia drogue in vivo et qu'il agit dans
la lumiCre de Ia partie large de Ia branche ascendante de l'anse
de Henle en inhibant Ic transport actif du chlore et, de cc fait,
en diminuant Ia reabsorption du NaCI.
Ethacrynic acid is one of the most potent diuretics known
[1—5]. Its principal site of action within the kidney has been
identified by clearance techniques as the ascending limb
of Henle's loop [2—4, 6]; however, the mechanism by which
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it inhibits NaCI reabsorption at this site is uncertain. The
thick ascending limb can be studied directly by means of
in vitro perfusion of tubule fragments dissected from rabbit
kidneys [7, 8]. Since the rabbit is one of the species in
which the drug is effective [1], a direct study of its action
in this preparation was of interest.
In previous studies it was found that NaCI reabsorption
from the thick ascending limb involves active transport of
chloride and is associated with a transepithelial electrical
potential difference (PD) oriented positive in the lumen
[7, 8]. The active Cl transport is inhibited by the presence
of ouabain in the bath [7, 8] and by furosemide [9] and
mersalyl [10] in the tubule lumen. The purpose of the pre-
sent studies was to investigate directly the action of etha-
crynic acid in this tubule segment.
Methods
The method employed in these studies has previously
been described in detail [7, 11] and is summarized below
with additions and modifications.
Cortical segments of thick ascending limbs of Henle's
loop were dissected from rabbit kidney and were perfused
at 37°C using concentric glass pipets.
The tubules were dissected at room temperature in the
saline buffer that was used in the bath during perfusion. It
contains the following (in millimoles): NaCI, 115; KCI, 5;
NaHCO3, 25; Na acetate, 10; CaCI2, 1; MgSO4, 1.2;
NaH2PO4, 1.2; glucose, 5; plus 5% v/v rabbit serum.
The perfusate contained NaCI, 150; K2HPO4, 2.5; CaCl2,
1.0; and MgSO4, 1.2, adjusted to pH 7.4 (unless otherwise
noted) with HCI.
Perfusions were carried out by gravity. Sodium and
potassium concentrations were measured in the perfusion
fluids and baths using an IL flame photometer, and
osmolality was measured using the Bowman-Aminco freez-
ing point apparatus [13]. Potassium was measured in
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microsamples of the perfusate and collected fluid using the
Aminco helium glow photometer [12]. Chloride was mea-
sured in bulk solutions using the Cotlove-Aminco chlorido-
meter [14] and in microsamples of perfused and collected
fluid using a modification [15] of the Ramsay method [16].
The transepithelial electrical PD was measured between
calomel cells connected to the fluids in the bath and per-
fusion pipet with bridges containing 0.16 M NaCI-agar.
The PD was displayed on an oscilloscope (Tektronix 561A)
and a recorder (Hewlett Packard 680 M) connected via an
amplifier (Bak ELSA-3 or 4). The PD was not corrected
for liquid junction potentials since those are small and
cannot be readily calculated for the complex solutions
used [17]. (The liquid junction potential with the standard
solutions listed above is approximately + 1.5 my which
would be subtracted from the recorded PD for correction.)
The transepithelial electrical resistance was calculated
by cable analysis using the voltage change at both ends of
the tubule resulting from passage of current from the per-
fusion pipet to a ground connected to the bath [18]. The
current (5 x 10-8 amp) was passed through the lumen of
the perfusion pipet. The voltage artifact resulting from the
passage of current through the perfusion pipet was nulled
with a bridge circuit [18].
Ethacrynic acid was provided by Merck, Sharpe, &
Dohme. It was alkalinized with NaOH in order to dissolve
it. Ethacrynic-cysteine was prepared by mixing the etha-
crynic acid solution with cysteine in a molar ratio of 1:1.1.
The ethacrynic-cysteine was freshly prepared during each
experiment since it lost activity after standing for a few
hours. Except as indicated, no rabbit serum was added to
the bath containing the ethacrynic acid or ethacrynic-
cysteine in order to avoid possible protein binding.
Results are given as mean standard error (number of
tubules studied). Statistical significance was estimated using
the Student's 1-test.
Results
The mear electrical PD across the epithelium of the
cortical thick ascending limb of Henle's loop is 6.4 2.0 SD
(lumen positive) when the solutions in the lumen and bath
contain equal concentrations of Na [7]. The PD results
from the active transport of Cl across the epithelium, and
it drives the Na transport which is largely, and possibly
entirely, passive [7].
Ethacrynic acid in the perfusate caused a decrease in the
electrical PD (Figs. 1, 2A, 3) similar to the effect of
furosemide [9] and the mercurial diuretic mersalyl [10].
The concentration of ethacrynic acid required is high
(Fig. 1). There was no effect with 10 M ethacrynic acid
in the lumen. A concentration of at least 3x 10 M was
required in order to cause the PD to decrease. Beyer et al [I]
have reported that most of the ethacrynic acid that is
administered to dogs appears in the urine in a chemically
modified form. One of the major urinary excretion pro-
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Fig. 1. Effect of ethacrynic acid in the lumen on the thick ascending
limb of Henle's loop. The PD is the steady value reached one to
ten minutes after adding the drug and is given as percent of the
initial control value.
ducts is the cysteine adduct of ethacrynic acid [1]. When
ethacrynic-cysteine was added to the perfusate in the pre-
sent experiments, the PD was inhibited by a much lower
concentration (Figs. 1, 2B, 4) than of ethacrynic acid, it-
self. Thus, 3 x 10 6 M ethacrynic-cysteine had an effect on
the PD (Fig. 2B) at least as great as that of l0— M etha-
crynic acid, indicating that the ethacrynic-cysteine is more
80 -
60 -
40-
20 -
• °Ethacrynic-cysteine
• Ethacrynic acid
. I
. S
0
0
800
8
0
0
0
00
10_o iO
0
Minutes
Fig. 2. Effect of ethacrynic acid (A) and ethacrynic-cysteine (B)
in the lumen on the thick ascending limb of Henle's loop. Repre-
sentative experiments are shown in order to illustrate the time
course at different concentrations of the drugs.
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Fig. 3. Effect of ethacrynic acid (0.3 to 2 X lO M) in the lumen
on the thick ascending limb of Henle's loop. The PD with the
drug is the steady value reached three to ten minutes after it
was added. The after control is the maximum value reached
10 to 30 minutes after drug was removed. The bar equals 2 SEM.
than 100 times as potent.' Net chloride transport was also
blocked by ethacrynic-cysteine (Table 1) which together
with the decrease in PD is most consistent with inhibition
by the drug of active chloride transport.2
The diuretic action of ethacrynic acid in vivo is notably
rapid both in its onset and in its reversibility. Consistent
with this, both ethacrynic acid and ethacrynic-cysteine
required only one to ten minutes to decrease the PD
maximally (Fig. 2) depending on the concentration used,
and the effect reversed substantially within 10 to 20 minutes
after the drug was removed (Figs. 2—4). The time course
in vitro is similar to that of the mercurial diuretic mersalyl
[10]. Furosemide in vitro is even more rapid in its action
and reversibility [9]. When ethacrynic acid was removed
from the lumen, the net chloride transport (Table I), as
well as the PD, returned toward the control value.
Ethacrynic acid (10 M) also caused the PD to decrease
when placed in the bath, provided the bath contained the
saline buffer without added protein (Fig. 5 and Table 2).
The decrease was not as rapid as when the drug was placed
in the lumen, however (compare Figs. 2 and 5), and there
As a control, cysteine alone (10 and iO— M) in the lumen
had no effect on the PD [10].
2 In two preliminary experiments net chloride transport was
also blocked by iO— M ethacrynic acid in the lumen.
Fig. 4. Effect of ethacrynic-cysteine (10 M) in the lumen on the
thick ascending limb of Henle's loop. The PD with the drug is the
steady value reached three to ten minutes after it was added.
The after control is the maximum value reached ten to thirty
minutes after the drug was removed. The bar equals 2 SEM.
was no reversal of the effect after the drug was removed.
In other preliminary experiments (not shown) concentra-
tions of ethacrynic acid lower than iO- M in the bath had
no definite effect on the PD. When the ethacrynic acid
(10 M) was dissolved in rabbit serum in the bath, there
was no effect on the PD (Table 2). (As a control, rabbit
serum, by itself in the bath, has little effect in transport [7]).
These results are similar to those previously observed when
mersalyl was placed in the bath in high concentrations.
Mersalyl in the bath caused the PD to decrease irreversibly,
Table 1. Effect of ethacrynic-cysteine in the lumen on the thick
ascending limb of Henle's loop a
Control
(Cl)
Ethacrynic-
cysteine(E), 3x l0
After
control
(C2)
12.0 1.4 5.5
5.2 0.8 3.2
10.8 3.5 7.2
11.4 3.9 7.0
Mean SEM 9.9 1.6 2.4 0.8 5.7 0.9
a As judged from chloride transport rate in pEq cm' scc1.
Each value is the mean of three collections from an individual
tubule taken over 15 to 25 minutes. The mean paired differ-
/ C1+C2\
ence E— 2 )was —5.4 0.8 SEM, P<0.01. The mean
tubule length was 2.2 mm and the mean perfusion rate was
1.9 nI min1. The mean concentrations of chloride were as
follows: bath, 119 mM; perfusate, 150 mM; and control col-
lected perfusion fluid, 83 m. Net chloride transport was cal-
culated as previously described [101 from the concentrations
of chloride in the perfused and collected fluid, assuming no
net fluid transport.
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Hg. 5. Effect of ethacrynic acid (1O— M) in the bath on the thick
ascending limb of Henle's loop. The bath contained no added
protein.
except in the presence of serum which prevented the mer-
salyl effect [19]. Ethacrynic cysteine (10—s) in the bath
had no effect on the PD even in the absence of added
protein (Table 2). This result is similar to that with furo-
semide which also has little effect in the bath [9].
In order to test whether the effect of ethacrynic-cysteine
in the lumen of the thick ascending limb of Henle's loop
is accompanied by any major change in sodium or chloride
permeability, the NaCI diffusion potential and electrical
resistance were measured. When the thick ascending limb
is perfused with a solution containing a lower NaCI con-
centration than in the bath, the electrical PD increases.
This is principally a consequence of a diffusion potential
Table 2. Effect of ethacrynic acid in the bath on the thick
ascending limb of Henle's loopa
Control Experi- After Tubules,
mental control N
Ethacrynic acid,
1O— M,saline buffer 6,5 1.6 1.0 3
Ethacrynic acid,IO M, rabbit serum 7.8 7.4 7.2 3
Ethacrynic-cysteine,
1O M,saline buffer 8.1 7.8 7.8 3
a As measured by electrical potential difference (PD) in milli-
volts. The PD was measured for 10 minutes in the presence
of the drug (Experimental) and for 10 to 20 minutes in the
subsequent period (After control).
the electrical resistance increased slightly without any
change in the diffusion PD for NaCI, it is likely that there
was a small decrease in the conductance of the epithelium
to both of the major ions present (Cl and Na). A similar
result was previously found with furosemide [9]. The
changes in sodium and chloride conductance induced by
both drugs are relatively minor, however, and the major
effect of the drugs evidently is to inhibit the active chloride
transport.
Ethacrynic acid and furosemide both cause an increase
in the urinary excretion of potassium as well as of sodium
[1—3, 6]. It is conceivable that inhibition by the drugs of
potassium reabsorption in the thick ascending limb of
Henle's loop might contribute to the kaliuresis. The results
of studies of potassium transport in this tubule segment
indirectly support the possibility. Potassium transport was
Table 3. Effect of ethacrynic cysteine and NaCI concentration in
the lumen on the thick ascending limb of Henle's loopa
Pert usate 150 50 150 50
[NaCI], mEq litert
Perfusate 0 0 105b iO
[Ethacrynic-cysteine], M
Tubule 1 8.3
PD,mV
30.5 3.0 25.2
2 8.7 32.8 1.1 28.0
3 7.3 31.0 1.6 22.0
4 7.2 32.1 0.5 25.8
5 8.4 30.8 0.9 26.0
Mean 8.0 31.5 1.4 25.4
Difference 23.5 24.0
8
7
6
5
E
3
2
across the epithelium, resulting from the imposed chemical
concentration gradient (sodium conductance exceeds chlo-
ride conductance) [7]. All other things being equal, the
magnitude of the diffusion potential depends on the ratio
of sodium to chloride conductance. In the experiments in
Table 3, tubules were perfused with solutions containing
both a normal (150 mM) and a low (50 mM) NaCl concen-
tration, The mean difference in PD with the two solutions
was approximately the same whether ethacrynic-cysteine
was present (24.0 my difference) or absent (23.5 my differ-
ence), indicating little change in the ratio of sodium to
chloride permeabilities with the drug. Ethacrynic-cysteine
(l0 M) in the lumen caused a small increase in the
electrical resistance. The mean electrical resistance in
5 tubules was 4280 ohm cm after the drug in the lumen
had caused the PD to decrease (E), compared to 3290 in
the preceding control periods (Cl) and 3790 10 to 20 min-
utes after removing the drug (C 2). The difference
I Cl+C2\
E — 2 ) was 740 270 SEM ohm cm (P =0.05). Since
1
a Each value of the PD is the mean of two readings taken one
minute apart. The perfusate with 50 mEq liteC' of NaCI was
otherwise identical to that containing 150 mEq liter'.
b Except for tubule 1 in which 3 x l06 M was used.
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studied in 31 experiments in 19 tubules (the results of
studies of sodium transport in most of these tubules was
reported previously [7]. Potassium concentration in the
bath and perfusate was 5 mEq liter'. In 14 experiments
the tubules were perfused with the standard solution con-
taining 150 mEq liter' of NaCI. The mean PD was
+6 my. There was a statistically insignificant increase in
potassium concentration in the collected fluid of 0.59
0.28 SEM mEq liter' (P >0.05). In 17 experiments the
tubules were perfused with solution containing 50 to
75 mEq liter1 of NaC1, but otherwise identical to the
standard solution. The mean PD was +19 my. There was
a mean decrease in potassium concentration in the collected
fluid of 0.76 0.26 mEq liteC1 (P <0.01). Therefore, there
was net potassium reabsorption, but only when the NaCI
concentration in the perfusate was low, as it presumably
is in the late portions of the ascending limb in viva. The
existence of net potassium reabsorption in the ascending
Henle's loop was previously deduced from micropuncture
experiments in which the potassium concentration in the
early distal tubule was found to be low [20, 21]. It is pos-
sible that the potassium reabsorption is passive since the
electrical gradient is favorable. Fractional potassium re-
absorption, however, is much less than sodium reabsorp-
tion studied in the same tubules. In the previous experi-
ments [7] with equal sodium concentration in lumen and
bath, sodium concentration decreased by approximately
35%, whereas, as indicated above, potassium concentra-
tion did not decrease at all under those conditions. Either
potassium permeability is less than sodium permeability
or there is an opposing active secretion of potassium (which
is also suggested by the equivocal increase in potassium
concentration under these conditions). Ethacrynic acid and
furosemide both cause the PD to decrease in the thick
ascending limb of Henle's loop and they prevented the fall
in NaCI concentration in the lumen. The combined result
could be to eliminate net potassium reabsorption in this
segment and thus add to the kaliuresis. Calcium is also
extensively reabsorbed in Henle's loop [22]. Calcium ex-
cretion is greatly increased by these diuretics [23, 24] and
part of the mechanism of this increase might be analogous
to that proposed above for potassium.
Discussion
Ethacrynic acid is one of a class of aryloxyacetic acid
derivatives that were synthesized in order to produce more
effective diuretic agents than the organic mercurials which
were the most potent diuretics then known [1]. Since the
mercurials were believed to act by inhibiting sulfhydryl-
catalyzed systems, the aryloxyacetic acid derivatives were
chosen for their selective reactivity with functionally im-
portant sulfhydryl groups [25]. Ethacrynic acid proved to
be an extremely potent diuretic [1—5], even more effective
than the organic mercurials [5]. At the time it was believed
that diuretics in general acted to inhibit active sodium
transport across the renal tubule epithelium and the dis-
covery of what was presumed to be a potent inhibitor of
sodium transport was of obvious interest. The effect of
ethacrynic acid on the intact kidney was studied by con-
ventional clearance and micropuncture techniques, and in
addition, the drug was tested in numerous other tissue
preparations in order to define its mechanism of action.
In human red blood cells that were already maximally
inhibited by ouabain, ethacrynic acid caused a further
decrease in sodium efflux [26—30] and potassium influx [29].
The drug also caused a decrease in sodium efflux and/or an
increase in cell sodium content in muscle cells [31—34], frog
oocytes [35], and intestinal epithelial cells [36]. Further,
ethycrynic acid caused an increase in renal cell water and
NaC1 content and a decrease of cell potassium content in
kidney slices and suspensions of renal tubules [37—41].
There were changes in metabolism, however, that could
not be completely explained on the basis of inhibition of
cation transport [34, 36], and it was suggested that some
of the effects of ethacrynic acid were secondary to inhibition
of cell metabolism rather than a primary effect of the drug
on a cation transport system [34, 40—42]. Ethacrynic acid
was found to inhibit respiration and glycolysis both in
intact cells and in tissue homogenates from nonrenal
[34, 43—46] and renal tissue [1, 47—51]. The inhibition of
renal metabolism required a concentration of ethacrynic
acid that exceeded that found in vivo, however, and the
effect was not regarded as related to the diuresis [48, 52].
Ethacrynic acid was also found to inhibit Na- and K-
activated adenosine triphosphatase (Na, K-ATPase) [1, 34,
48, 53—63]. The effect of ethacrynic acid on the renal
ATPase was not specific, however, as was that of ouabain.
Whereas ouabain inhibited Na- and K-activated, but not
Mg-activated ATPase activity, ethacrynic acid inhibited
both [34,56, 57, 62].
It is evident that ethacrynic acid has a number of differ-
ent biological actions. We believe, however, that the
diuretic effect may be distinct from all of these and that,
whereas the other effects may involve reactions with tissue
sulfhydryl groups, the diuretic effect may not. These con-
clusions are principally based on the findings in the present
studies that 1) the ethacrynic-cysteine complex in the
tubule lumen is more than 100 times more effective than
ethacrynic acid itself in inhibiting NaC1 absorption in the
thick ascending limb of Henle's loop and that 2) it is
active chloride transport that is inhibited by the drug,
rather than active sodium transport, as previously believed.
Most of the in vitro effects of ethacrynic acid are elicited
only by a high concentration of the drug. Approximately
iO M was used in most of the studies quoted above and
10 M generally had little if any effect. Further, the addition
of cysteine or dithiothreitol blocked the effect of ethacrynic
acid [1, 28, 47, 62, 64]. A similarly high concentration of
ethacrynic acid was required to decrease the PD across
the thick ascending limb of Henle's loop. In contrast to the
effects in other tissues, however, premixing the ethacrynic
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acid with cysteine greatly increased its effectiveness in the
lumen of renal tubule (although only the ethacrynic-
cysteine complex is referred to here, it is possible that other
analogous complexes are formed and have a similar effect).
Cysteine should block the reactivity of ethacrynic acid
with other sulfhydryl groups rather than enhance it. It is
conceivable that cysteine facilitated the access of ethacrynic
acid to sulfhydryl-containing receptors in the thick as-
cending limb of Henle's loop, but not in other tissues. We
consider this possibility unlikely, however, and question
whether diuresis in vivo involves sulfhydryl inhibition, as
was previously believed. In support of our view, Beyer
et al [1] noted that the diuretic effect of ethacrynic acid is
not readily reversed by dimercaprol (BAL) as it might be
were inhibition of sulfhydryl-containing enzymes essential
to its action. In fact, there is little evidence that reactivity
with sulfhydryl groups is involved in the diuretic action of
ethycrynic acid except for the observation that the concen-
tration of protein-bound sulfhydryl groups in dog kidneys
is reduced [65] by the drug.
If ethacrynic-cysteine is the form of the drug that causes
diuresis, it is possible to explain why ethacrynic acid is
relatively nontoxic when used as a diuretic despite the
multiple nonspecific effects mentioned above. The non-
specific effects of ethacrynic acid (e.g., its effects on
metabolism and nonrenal sodium transport) could be
prevented in vivo by complexing of the drug with proteins
or cysteine in plasma. The drug could then be concen-
trated in proximal tubule cells and secreted into the urine
by the organic acid transport system (1]. Prior to or during
this process, the ethacrynic acid could be converted to
ethacrynic-cysteine. Consistent with this view, ethacrynic
acid, when incubated with kidney cells in vitro, becomes
complexed to cysteine [55]. This mechanism explains how
a compound as reactive as ethacrynic acid can greatly
reduce NaCI reabsorption in the thick ascending limb of
Henle's loop without causing nonspecific effects in the
kidney and other tissues. Not only is the ethacrynic-
cysteine complex less toxic, but lower concentrations are
required than of ethacrynic acid to inhibit NaCI reabsorp-
tion in the ascending limb of Henle's loop. Thus, the con-
centration of ethacrynic acid (1O M) necessary to decrease
the PD when placed in the lumen of the thick ascending
limb caused an irreversible inhibition of the PD when
placed in the bath, but a concentration of ethacrynic
cysteine greater than that effective in the lumen had no
effect when placed in the bath (10 M in the bath vs.
3 x 106ri in the lumen).
Since ethacrynic cysteine decreased both the PD across
the thick ascending limb of Henle's loop and the net ab-
sorption of chloride without any major change in sodium
or chloride conductance, the drug most likely acts by
inhibiting active chloride transport. This conclusion is
consistent with the observation that chloride (not HCO3)
excretion is specifically increased by the drug [1—4, 6, 66].
In most tissues the principal ions that are actively trans-
ported are sodium and potassium, and the mechanism of
transport is believed to involve Na, K-ATPase. As dis-
cussed previously, it is difficult to see how the inhibition
of Na- and K-activated ATPase by diuretic drugs could
directly explain their inhibition of the active chloride
transport system in the thick ascending limb of Henle's
loop [9]. In addition, it seems unlikely that inhibition of
the Na- and K-activated ATPase could be involved in the
diuretic action of ethacrynic acid since inhibition of the
active chloride transport is enhanced by addition of
cysteine to ethacrynic acid, whereas inhibition of ATPase
is reduced by cysteine [1, 62].
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